Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial

  1. Ye, N.
  2. Jardine, M.J.
  3. Oshima, M.
  4. Hockham, C.
  5. Heerspink, H.J.L.
  6. Agarwal, R.
  7. Bakris, G.
  8. Schutte, A.E.
  9. Arnott, C.
  10. Chang, T.I.
  11. Górriz, J.L.
  12. Cannon, C.P.
  13. Charytan, D.M.
  14. De Zeeuw, D.
  15. Levin, A.
  16. Mahaffey, K.W.
  17. Neal, B.
  18. Pollock, C.
  19. Wheeler, D.C.
  20. Luca Di Tanna, G.
  21. Cheng, H.
  22. Perkovic, V.
  23. Neuen, B.L.
Revue:
Circulation

ISSN: 1524-4539,  0009-7322

Année de publication: 2021

Volumen: 143

Número: 18

Pages: 1735-1749

Type: Article

DOI: 10.1161/CIRCULATIONAHA.120.048740 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus